These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9292401)

  • 1. Preparation and properties of a stable intravenous lorazepam emulsion.
    Yalin M; Oner F; Oner L; Hincal AA
    J Clin Pharm Ther; 1997 Feb; 22(1):39-44. PubMed ID: 9292401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interfacial properties as stability predictors of lecithin-stabilized perfluorocarbon emulsions.
    Yoon JK; Burgess DJ
    Pharm Dev Technol; 1996 Dec; 1(4):333-41. PubMed ID: 9552317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of ultrasound to prepare lipid emulsions of lorazepam for intravenous injection.
    Medina J; Salvadó A; del Pozo A
    Int J Pharm; 2001 Mar; 216(1-2):1-8. PubMed ID: 11274800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naproxen incorporated lipid emulsions. I. Formulation and stability studies.
    Nasirideen S; Kaş HS; Oner F; Alpar R; Hincal AA
    J Clin Pharm Ther; 1998 Feb; 23(1):57-65. PubMed ID: 9756113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulating a poorly water soluble drug into an oral solution suitable for paediatric patients; lorazepam as a model drug.
    van der Vossen AC; van der Velde I; Smeets OS; Postma DJ; Eckhardt M; Vermes A; Koch BC; Vulto AG; Hanff LM
    Eur J Pharm Sci; 2017 Mar; 100():205-210. PubMed ID: 28126558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel parenteral formulation for tetrazepam using a lipid emulsion.
    Jumaa M; Müller BW
    Drug Dev Ind Pharm; 2001 Nov; 27(10):1115-21. PubMed ID: 11794814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving emulsification efficacy of lecithin by formulation design. I: Effect of adding a secondary surfactant.
    Krishna G; Wood GC; Sheth BB
    PDA J Pharm Sci Technol; 1998; 52(6):331-6. PubMed ID: 10050132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propylene glycol accumulation during continuous-infusion lorazepam in critically ill patients.
    Wilson KC; Farber HW
    J Intensive Care Med; 2008; 23(6):413; author reply 414-5. PubMed ID: 19019841
    [No Abstract]   [Full Text] [Related]  

  • 9. Impact of different emulsifiers on biocompatibility and inflammatory potential of Perfluorohexyloctane (F6H8) emulsions for new intravenous drug delivery systems.
    Tsagogiorgas C; Anger F; Beck G; Breedijk A; Yard B; Hoeger S
    Drug Des Devel Ther; 2019; 13():2097-2110. PubMed ID: 31417241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The elimination peculiarities of perfluorocarbon emulsions stabilized with egg yolk phospholipid.
    Putyatina TK; Aprosin UD; Afonin NI
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1281-5. PubMed ID: 7849934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of lorazepam microemulsions for parenteral delivery.
    Kale AA; Patravale VB
    AAPS PharmSciTech; 2008; 9(3):966-71. PubMed ID: 18720016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic determination of lorazepam in monkey plasma.
    Walmsley LM; Chasseaud LF
    J Chromatogr; 1981 Nov; 226(1):155-63. PubMed ID: 6119319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precipitation of lorazepam infusion.
    Boullata JI; Gelone SP; Mancano MA; Borenstein MR; Zitterman RE
    Ann Pharmacother; 1996 Sep; 30(9):1037-8. PubMed ID: 8876873
    [No Abstract]   [Full Text] [Related]  

  • 14. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative trial of intravenous lorazepam and clonazepam im status epilepticus.
    Sorel L; Mechler L; Harmant J
    Clin Ther; 1981; 4(4):326-36. PubMed ID: 6120763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lyophilization on parenteral emulsions.
    Krishna G; Sheth BB
    PDA J Pharm Sci Technol; 1999; 53(6):318-23. PubMed ID: 10754731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between erythrocytes from various animals and emulsions stabilized with various lecithins.
    Ishii F; Nagasaka Y; Ogata H
    J Pharm Sci; 1989 Apr; 78(4):303-6. PubMed ID: 2724093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration.
    Wermeling DP; Miller JL; Archer SM; Manaligod JM; Rudy AC
    J Clin Pharmacol; 2001 Nov; 41(11):1225-31. PubMed ID: 11697755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lorazepam levels. A study following single dose administration of 2 and 4 mg by different routes.
    Dundee JW; Lilburn JK; Toner W; Howard PJ
    Anaesthesia; 1978 Jan; 33(1):15-9. PubMed ID: 24357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diarrhea associated with enteral benzodiazepine solutions.
    Marshall JD; Farrar HC; Kearns GL
    J Pediatr; 1995 Apr; 126(4):657-9. PubMed ID: 7699551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.